3645 results for «644»

Filter By

3645 results

Unconventional situations during cardiovascular interventions

20 May 2026 – From EuroPCR 2026

This session addresses unconventional and challenging scenarios encountered during cardiovascular interventions, focusing on managing complications effectively in the cathlab. Through detailed case presentations from Argentina, Chile, and Colombia, it explores innovative approaches to acute aortic valve regurgitation, TAVI complications in bicuspid anatomy, and diagnostic dilemmas in...

To rescue the unexpected complications during TAVI

20 May 2026 – From EuroPCR 2026

This session focuses on the recognition and management of unexpected complications during TAVI procedures. Through cases from Hong Kong, Kazakhstan, and Uzbekistan, it examines mechanisms underlying common and rare complications such as aortic sinus injury, acute valve dislocation, and left main collapse. Attendees gain practical insights...

Lessons from the long-term DES data: how they can inform today's practice

20 May 2026 – From EuroPCR 2026

This session reviews long-term clinical data on drug-eluting stents (DES) and bioresorbable scaffolds (BRS), offering valuable insights to inform current interventional cardiology practice. It covers seven-year outcomes of magnesium scaffolds in ACS, five-year results of sirolimus-eluting iron BRS, and extensive post-market studies of various thin-strut and...

TAVI procedural complications - Part 4: vascular complications, coronary issues and more

20 May 2026 – From EuroPCR 2026

This session addresses a spectrum of procedural complications encountered in TAVI, focusing on vascular issues, coronary challenges, and device-related difficulties. Case presentations include partial prosthesis expansion, emergency thoracic aortic stenting, repeat balloon valvuloplasty, revascularization dilemmas, and complex valve-in-valve procedures. The discussion provides practical perspectives on managing...

The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial

25 Oct 2023

Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...

Nicola Ryan

Author

Nicola Ryan
Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement System in High-Risk Patients with Symptomatic Severe Native Aortic Regurgitation (ALIGN-AR)
Didn’t find what you were looking for?